Section
E13.354
Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment
Hierarchy
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Use Additional
-
code to identify control using:
-
injectable non-insulin antidiabetic drugs (Z79.85)
- Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
-
insulin (Z79.4)
- Z79.4 Long term (current) use of insulin
-
oral antidiabetic drugs (Z79.84)
- Z79.84 Long term (current) use of oral hypoglycemic drugs
-
oral hypoglycemic drugs (Z79.84)
- Z79.84 Long term (current) use of oral hypoglycemic drugs
Includes
-
diabetes mellitus due to genetic defects of beta-cell function
-
diabetes mellitus due to genetic defects in insulin action
-
postpancreatectomy diabetes mellitus
-
postprocedural diabetes mellitus
-
secondary diabetes mellitus NEC
Excludes 1
-
diabetes (mellitus) due to autoimmune process (E10.-)
- E10 Type 1 diabetes mellitus
-
diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
- E10 Type 1 diabetes mellitus
- E08 Diabetes mellitus due to underlying condition
- E09 Drug or chemical induced diabetes mellitus
-
gestational diabetes (O24.4-)
- O24.4 Gestational diabetes mellitus
- P70.2 Neonatal diabetes mellitus
- E10 Type 1 diabetes mellitus
- P70-P74 Transitory endocrine and metabolic disorders specific to newborn (P70-P74)